文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒性休克流行病学特征及预后危险因素分析

[Analysis of epidemiological features and prognostic risk factors in septic shock].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论基于eICU数据库5564例脓毒性休克患者的回顾性队列显示,ICU死亡率为21.30%、院内死亡率为29.39%、ICU再入院率为16.30%,并识别出16个ICU死亡独立危险因素。

该研究为基于eICU协作研究数据库的回顾性队列研究,纳入2014至2015年5564例脓毒性休克患者,分析其流行病学特征、ICU死亡率、院内死亡率及ICU再入院率,并用多因素Logistic回归识别ICU死亡的独立危险因素。结果显示ICU死亡率为21.30%、院内死亡率为29.39%、ICU再入院率为16.30%,脓毒性休克占全部ICU入院的3.3103%、占脓毒症患者的24.869%。共识别出16个独立危险因素,包括女性、高龄、低BMI、社区医院入院、较高SOFA评分、较高APS III评分、COPD、严重肝病或转移性实体瘤合并症、肺部感染、心率增快、呼吸增快、收缩压降低、体温降低、RRT及血清乳酸升高。

要点

  • 脓毒性休克患者ICU死亡率为21.30%(1416/6649),院内死亡率为29.39%(1954/6649),ICU再入院率为16.30%(1084/6649)。
  • 多因素Logistic回归显示较高SOFA评分(OR=1.110,95%CI 1.081-1.140,P<0.001)和较高APS III评分(OR=1.120,95%CI 1.085-1.156,P<0.001)与ICU死亡独立相关。
  • 血清乳酸升高(OR=1.171,95%CI 1.144-1.198,P<0.001)和需要RRT(OR=1.533,95%CI 1.117-2.086,P=0.007)为ICU死亡的独立危险因素。
  • 合并严重肝病(OR=1.652,95%CI 1.226-2.214,P<0.001)或转移性实体瘤(OR=1.441,95%CI 1.184-1.749,P<0.001)的患者ICU死亡风险更高。
  • 社区医院入院(OR=1.548,95%CI 1.321-1.814,P<0.001)及肺部感染(OR=1.423,95%CI 1.210-1.674,P<0.001)亦为ICU死亡的独立危险因素。

适用人群与场景

  • eICU协作研究数据库中2014至2015年的脓毒性休克患者,共5564例,年龄(66.31±15.84)岁(范围18-91岁),男性2903例、女性2661例。
  • 多数患者首次入住内科ICU[79.31%(4413/5564)],63.93%(3557/5564)来自床位≥250张的医院。

研究设计与关键结果

  • 研究类型为回顾性队列研究,样本量5564例,数据来源为eICU协作研究数据库2014至2015年脓毒性休克患者。
  • 常见合并症包括心脑血管疾病[35.14%(1955/5564)]、糖尿病[31.99%(1780/5564)]、肝脏/肾脏疾病[23.89%(1329/5564)]。
  • 主要原发感染部位为肺部[34.38%(1913/5564)]和泌尿道[21.53%(1198/5564)],14.41%(802/5564)合并两种或以上感染。
  • 55.10%(3066/5564)使用血管升压药,5.66%(315/5564)接受肾脏替代治疗(RRT),72.09%(4011/5564)接受有创机械通气。
  • 在整个eICU人群中,脓毒性休克患者占全部ICU入院的3.3103%(6649/200859),占脓毒症患者的24.869%(6649/26736)。
  • ICU死亡率为21.30%(1416/6649),院内死亡率为29.39%(1954/6649),ICU再入院率为16.30%(1084/6649)。
  • 多因素Logistic回归识别16个ICU死亡独立危险因素:女性(OR=1.209,95%CI 1.035-1.411,P=0.016)、高龄(OR=1.018,95%CI 1.186-1.329,P<0.001)、低BMI(OR=0.950,95%CI 0.907-0.995,P=0.030)、社区医院入院(OR=1.548,95%CI 1.321-1.814,P<0.001)、较高SOFA评分(OR=1.110,95%CI 1.081-1.140,P<0.001)、较高APS III评分(OR=1.120,95%CI 1.085-1.156,P<0.001)、COPD(OR=1.221,95%CI 1.152-1.451,P<0.001)、严重肝病(OR=1.652,95%CI 1.226-2.214,P<0.001)、转移性实体瘤(OR=1.441,95%CI 1.184-1.749

证据类型、等级与局限

  • 证据类型:基于eICU协作研究数据库的回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究提示女性、高龄、低BMI、社区医院入院、较高SOFA评分、较高APS III评分、合并COPD、严重肝病或转移性实体瘤、肺部感染、心率增快、呼吸增快、收缩压降低、体温降低、RRT及血清乳酸升高的脓毒性休克患者ICU死亡风险更高。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the epidemiological characteristics of septic shock and identify high risk factors influencing the prognosis based on the eICU Collaborative Research Database.

METHODS: A retrospective cohort study was conducted. Data of patients with septic shock from 2014 to 2015 in the eICU Collaborative Research Database were collected, including demographic information, general information of intensive care unit (ICU) and hospital, severity scores of illness, comorbidities, primary infection site, vital signs, interventions, serum lactic acid, and outcome measures. Epidemiological characteristics of the septic shock population were analyzed, as well as the ICU mortality, in-hospital mortality, and ICU readmission rate. Multivariate Logistic regression analysis was used to identify independent risk factors for ICU death in patients with septic shock.

RESULTS: A total of 5 564 patients with septic shock were enrolled, comprising 2 903 males and 2 661 females. The age was (66.31±15.84) years (ranged 18-91 years), and body mass index (BMI) was (28.84±9.34) kg/m2 (ranged 10.72-121.67 kg/m2). The majority were first admitted to a medical ICU [79.31% (4 413/5 564)], and a higher proportion were hospitals with ≥250 beds [63.93% (3 557/5 564)]. The Sequential Organ Failure Assessment (SOFA) score was 8.51±3.83 (ranged 2-23), Acute Physiology Score III (APS III) was 67.73±29.89 (ranged 7-200), and Acute Physiology And Chronic Health Evaluation IV (APACHE IV) score was 81.57±30.85 (ranged 9-205). Common comorbidities included cardiovascular and cerebrovascular diseases [35.14% (1 955/5 564)], diabetes [31.99% (1 780/5 564)], and liver/kidney diseases [23.89% (1 329/5 564)]. The main primary infection site was pulmonary [34.38% (1 913/5 564)] and urinary tract infections [21.53% (1 198/5 564)]; 14.41% (802/5 564) had two or more concurrent infections. 55.10% (3 066/5 564) received vasopressors, 5.66% (315/5 564) received renal replacement therapy (RRT), and 72.09% (4 011/5 564) received invasive mechanical ventilation. Within the entire eICU population, septic shock patients accounted for 3.310 3% (6 649/200 859) of the total ICU admissions, and accounted for 24.869% (6 649/26 736) of the sepsis patients. The ICU mortality for septic shock patients was 21.30% (1 416/6 649), the in-hospital mortality was 29.39% (1 954/6 649), and the ICU readmission rate was 16.30% (1 084/6 649). Multivariate Logistic regression analysis identified 16 independent risk factors associated with ICU death in patients with septic shock, including female [odds ratio (OR)=1.209, 95% confidence interval (95%CI) was 1.035-1.411, P=0.016], advanced age (OR=1.018, 95%CI was 1.186-1.329, P<0.001), low BMI (OR=0.950, 95%CI was 0.907-0.995, P=0.030), admission in community hospital (OR=1.548,95%CI was 1.321-1.814, P<0.001), higher SOFA score (OR=1.110, 95%CI was 1.081-1.140, P<0.001), higher APSIII score (OR=1.120, 95%CI was 1.085-1.156, P<0.001), comorbidities of chronic obstructive pulmonary disease (OR=1.221, 95%CI was 1.152-1.451, P<0.001), severe liver disease (OR=1.652, 95%CI was 1.226-2.214, P<0.001), or metastatic solid tumor (OR=1.441, 95%CI was 1.184-1.749, P<0.001), pulmonary infection (OR=1.423, 95%CI was 1.210-1.674, P<0.001), increased heart rate (OR=1.082, 95%CI was 1.041-1.126, P<0.001), increased respiratory rate (OR=1.129, 95%CI was 1.067-1.194, P<0.001), decreased systolic blood pressure (OR=0.942, 95%CI was 0.902-0.983, P<0.001), decreased body temperature (OR=0.857, 95%CI was 0.796-0.923, P<0.001), RRT (OR=1.533, 95%CI was 1.117-2.086, P=0.007), and elevated serum lactic acid (OR=1.171, 95%CI was 1.144-1.198, P<0.001).

CONCLUSIONS: The ICU mortality for patients with septic shock was 21.30%, in-hospital mortality was 29.39%, and the ICU readmission rate was 16.30%. Female, advanced age, low BMI, admission in community hospital, higher SOFA score, higher APS III score, comorbidities of chronic obstructive pulmonary disease, severe liver disease, or metastatic solid tumor, pulmonary infection, increased heart rate, increased respiratory rate, decreased systolic blood pressure, decreased body temperature, RRT, and elevated serum lactic acid are high risk factors for death in ICU in the patients with septic shock.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li Z, Zhang Y, Liu S, et al. [Analysis of epidemiological features and prognostic risk factors in septic shock]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 41833344. doi:10.3760/cma.j.cn121430-20241203-00573

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。